KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Historic Short term Debt for Twist Bioscience (TWST) over the last 4 years, with Q4 2021 value amounting to $9.1 million.

  • Twist Bioscience's Short term Debt rose 17248.72% to $9.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.1 million, marking a year-over-year increase of 17248.72%. This contributed to the annual value of $1.6 million for FY2021, which is 5343.53% down from last year.
  • Per Twist Bioscience's latest filing, its Short term Debt stood at $9.1 million for Q4 2021, which was up 17248.72% from $1.6 million recorded in Q3 2021.
  • In the past 5 years, Twist Bioscience's Short term Debt ranged from a high of $9.1 million in Q4 2021 and a low of $1.6 million during Q3 2021
  • For the 4-year period, Twist Bioscience's Short term Debt averaged around $3.5 million, with its median value being $3.3 million (2018).
  • The largest annual percentage gain for Twist Bioscience's Short term Debt in the last 5 years was 17248.72% (2021), contrasted with its biggest fall of 5343.53% (2021).
  • Quarter analysis of 4 years shows Twist Bioscience's Short term Debt stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then surged by 172.49% to $9.1 million in 2021.
  • Its last three reported values are $9.1 million in Q4 2021, $1.6 million for Q3 2021, and $2.4 million during Q2 2021.